Clinical Trials Browser

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Bone Marrow Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

Erectile Dysfunction, Prostatic Neoplasms

Neuroblastoma, Ganglioneuroblastoma

Multiple Myeloma

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Thyroid Neoplasms

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

Carcinoma, Hepatocellular

Multiple Myeloma

Pancreatic Neoplasms

Gastroesophageal Cancer

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

Carcinoma, Merkel Cell

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

High-risk Non-muscle-invasive Bladder Cancer

Locally Advanced or Metastatic Solid Tumors

Colorectal Cancer, Hereditary Nonpolyposis, Type 6, Carcinoma, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

Advanced Solid Tumors

Advanced Solid Tumors

Lymphoma, T-Cell

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Multiple Myeloma

Advanced Solid Tumor Cancer

Multiple Myeloma

Differentiated Thyroid Cancer

Leukemia, Myeloid, Acute

Glioblastoma

Pancreatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Advanced Solid Tumor Cancer

Solid Tumours

Colorectal Neoplasms

Advanced Unresectable or Metastatic Breast Cancer of Adults

Breast Neoplasms, Prostatic Neoplasms

Colorectal Neoplasms

Malignant Solid Tumors

Carcinoma, Non-Small-Cell Lung

Lymphoma, B-Cell

Multiple Myeloma

Lymphoma, B-Cell

Glioblastoma

Squamous Cell Carcinoma of Head and Neck

Ovarian Neoplasms

Clinical Trials

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Stem Cells for Erectile Dysfunction Post RALP

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

PRISM-TAMP

HER-OIC

MDS

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

SYS6090 Combination Therapy in Advanced Lung Cancer

A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

KontRASt-R

GRACE

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

PRiME II

SKB103 for Injection in Advanced Solid Tumors

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

BEXAR

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

QLS5132 Combination Therapy in Advanced Solid Tumors

To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma

Empirical Radioactive Iodine Therapy in DTC

A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)

ADePT

(BLOOM)

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG.

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

PARTHENON

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

EVER-RECODE

A Study of TAK-505 in Adults With Solid Tumors

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.